Australia's 4DMedical jumps on Canada nod for lung imaging tech approval

4DMedical

15/12/2025 01:23

** Shares of Australia's 4DMedical 4DX.AX rise as much as 9.5% to A$2.43, their highest since October 6

** Medtech firm receives Canadian regulatory approval for CT:VQ, CT-based lung ventilation–perfusion imaging technology

** Approval enables immediate commercial deployment of CT:VQ across Canada through strategic partnership with Philips

** About 3.4 million shares change hands, nearly 1.1x 30-day average

** 4DX has gained more than five-fold in value so far this year

 (Reporting by Keshav Singh Chundawat in Bengaluru)

 ((Keshav.singhchundawat@thomsonreuters.com))